Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 810 results for "Treatment For Multiple Sclerosis"

Concert to raise funds to treat MS patients
Deccan Chronicle

Concert to raise funds to treat MS patients

Chennai: The Multiple Sclerosis Society of India, Chennai Chapter, has planned a concert to raise funds to treat the MS patients. The event: Ek Main aur Ek tu will bring alive the magical romance of the leading on- screen pairs of Bollywood — in ... Deccan Chronicle, 20 hours ago

45 images for Treatment For Multiple Sclerosis

Bluffton Today, 2 weeks ago
Proactive Investors Australia, 1 day ago
Capital Bay, 4 weeks ago
Hngn.com, 3 weeks ago
MDLinx, 5 days ago
MDLinx, 1 week ago
MDLinx, 1 month ago
NigerianHerald.com, 2 weeks ago
Medical Xpress, 2 months ago
Pharmaceutical Journal, 2 months ago
IChainnel

Sandoz launches multiple sclerosis therapy in US

Sandoz, a provider of generic pharmaceuticals, has launched Glatopa, a one-time-daily multiple sclerosis therapy, in the US. "Sandoz, together with Momenta, is proud to announce the US market launch of a fully substitutable generic version of this ...
 Individual.com1 week ago Sandoz launches Glatopa in US market to treat multiple sclerosis  PharmaBiz2 weeks ago Sandoz launches the 1st version of multiple sclerosis drugs in US  IChainnel2 weeks ago

Biotin benefits clinically relevant in progressive multiple sclerosis

medwireNews: Patients with progressive multiple sclerosis (MS) and their clinicians see clear improvements during treatment with a high dose of biotin, show further results from the phase III trial of the therapy. After 12 months of treatment, the ...
 MedWire News2 weeks ago

Canadians with Multiple Sclerosis One Step Closer to Accessing LEMTRADA®

Common Drug Review recommends funding the only MS treatment given once a year for two years MISSISSAUGA, ON, June 22, 2015 /CNW/ - Genzyme Canada announced today that the Canadian Drug Expert Committee (CDEC), through the Common Drug Review (CDR), ...
 Canada NewsWire2 weeks ago Genzyme Canada Release: Canadians With Multiple Sclerosis One Step Closer To Accessing LEMTRADA  BioSpace2 weeks ago
[x]  

Natco Pharma gains as US Supreme Court invalidates rival Teva's patent for Copaxone

Copaxone (Glatiramer Acetate) is used in the treatment of relapsing-remitting multiple sclerosis.
 Economic Times2 weeks ago Natco Pharma wins US patent case against Teva  Manufacturing Chemist10 hours ago US Supreme Court invalidates Teva patent for Copaxone  Business Standard2 weeks ago
TheStreet.com

MedDay reports additional positive data from Phase III trial of MD1003 to treat progressive multiple sclerosis

MedDay, a biotechnology company focused on the treatment of nervous system disorders, reports additional positive data from its pivotal Phase III clinical trial, MS-SPI, with MD1003, a highly-concentrated pharmaceutical grade biotin, in patients ...
 Pharmaceutical Business Review2 weeks ago KONINKLIJKE DSM : MedDay and DSM announce a partnership to produce pharmaceutical grade D-Biotin to treat progressive multiple sclerosis  4 Traders2 weeks ago MedDay and DSM announce a partnership to produce pharmaceutical grade D-Biotin to treat progressive multiple sclerosis  Pharmacy Choice2 weeks ago Results of Multiple Sclerosis Drug Trail to be Presented at Neurology Annual Meeting  Med India2 months ago
[x]  

Momenta Pharmaceuticals unveils once daily Glatopa for treating patients with relapsing forms of multiple sclerosis

Biotechnology company Momenta Pharmaceuticals (Nasdaq GS:MNTA) revealed on Thursday the US launch of once daily Glatopa (glatiramer acetate injection) for treating patients with relapsing forms of multiple sclerosis through Sandoz. Glatopa ...
 Bloomberg2 weeks ago

NZ Multiple Sclerosis Research Trust officially launched

The New Zealand Multiple Sclerosis Research Trust ("NZMSRT") today announces it has received a combined $900,000 investment portfolio as founding capital for the Trust. A $600,000 portfolio has been transferred from the Multiple Sclerosis Society ...
 Voxy.co.nz5 days ago Multiple Sclerosis: Treatment and Global Market 2014-2019  Franklin Credit Management Corporation6 days ago Global Uveitis Treatment Market Worth US$ 822.5 Million by 2020, by Persistence Market Research  Digital Journal1 week ago MULTIPLE SCLEROSIS : Treatment and Global Market 2014-2019  4 Traders6 days ago
[x]  

Roche gets boost as multiple sclerosis drug works in big trials

ZURICH, June 30 (Reuters) - A drug being developed by Roche to treat multiple sclerosis (MS) met main and secondary objectives in two studies, boosting the company's hopes of expanding beyond its core cancer franchise. The studies of MS treatment ...
 Sharenet1 week ago UPDATE 1-Roche gets boost as multiple sclerosis drug works in big trials  Reuters UK1 week ago A New Multiple Sclerosis Treatment May Be On The Horizon  Medical Daily2 weeks ago
[x]  

Non-Insured Health Benefits Program Approves AUBAGIO(TM) for Relapsing Remitting Multiple Sclerosis

Once-daily oral tablet to be reimbursed for first-line use through exception process MISSISSAUGA, ON , June 24, 2015 /CNW/ - Genzyme Canada announced today that Health Canada has approved AUBAGIO (teriflunomide) 14 mg as an expedited exception ...
 Wall Street Business Network1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Treatment For Multiple Sclerosis
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less